Across TCGA pan-cancer cohorts, RPL32P15 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPL32P15’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RPL32P15 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL32P15 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

LUAD, STAD, and COAD are the cancer types where RPL32P15 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P15 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.082	.013	2	view →
STAD	Male	III,IV	−0.360	.027	1	view →
COAD	Male	III,IV	+0.275	.027	1	view →
THCA	Female	II,III,IV	+0.136	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RPL32P15 RNA expression & survival · all RPL32P15 data types